Onconova Therapeutics, Inc. 4
4 · Onconova Therapeutics, Inc. · Filed Jan 19, 2017
Insider Transaction Report
Form 4
Maniar Manoj
SVP - Product Development
Transactions
- Award
Stock Option (right to purchase)
2017-01-17+19,413→ 19,413 totalExercise: $2.70Exp: 2027-01-17→ Common Stock (19,413 underlying)
Footnotes (1)
- [F1]These options vest over three years in 36 equal monthly installments.